Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
PleoPharma Raises $36M in Series B to Advance Cannabis-Related Therapies
Series BVenture Capital

PleoPharma Raises $36M in Series B to Advance Cannabis-Related Therapies

•October 21, 2025
•Oct 21, 2025
0

Participants

PleoPharma

PleoPharma

company

Deal Summary

PleoPharma, a clinical-stage company developing treatments for cannabis-related neuropsych and addiction issues, closed a $36M Series B financing. The round was undisclosed as to backers and will support clinical development efforts under CEO Ginger Constantine, MD.

0

Comments

Want to join the conversation?

Loading comments...